Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chantal Mathieu

Showing results (41-50 of 625) with videos related to

Pageof 63
Sort By:
Expert Review of Proteomics|April 13, 2006
Type 1 diabetes: entering the proteomic eraWannes D'Hertog, Chantal Mathieu, Lut Overbergh
Current Opinion in Endocrinology, Diabetes, and Obesity|December 14, 2020
Advances in newer basal and bolus insulins: impact on type 1 diabetesJoke Vliebergh, Eveline Lefever, Chantal Mathieu
Therapeutic Advances in Endocrinology and Metabolism|August 13, 2020
SGLT inhibitors in type 1 diabetes: weighing efficacy and side effectsBirgit Janssens, Simon Caerels, Chantal Mathieu
Expert Review of Molecular Diagnostics|December 20, 2005
Quantification of chemokines by real-time reverse transcriptase PCR: applications in type 1 diabetesLut Overbergh, Conny Gysemans, Chantal Mathieu
The Journal of Endocrinology|March 17, 2021
100 YEARS OF INSULIN: Arresting or curing type 1 diabetes: an elusive goal, but closing the gapPieter-Jan Martens, Conny Gysemans, Chantal Mathieu
Molecular and Cellular Endocrinology|May 3, 2017
Vitamin D endocrinology on the cross-road between immunity and metabolismAn-Sofie Vanherwegen, Conny Gysemans, Chantal Mathieu
Endocrinology and Metabolism Clinics of North America|October 30, 2017
Regulation of Immune Function by Vitamin D and Its Use in Diseases of ImmunityAn-Sofie Vanherwegen, Conny Gysemans, Chantal Mathieu
Diabetes Care|April 29, 2011
Vitamin D deficiency is not good for youChantal Mathieu, Bart J Van der Schueren
The Proceedings of the Nutrition Society|September 17, 2002
1,25-dihydroxycholecalciferol: endocrinology meets the immune systemEvelyne van Etten, Brigitte Decallonne, Chantal Mathieu
Current Treatment Options in Cardiovascular Medicine|March 17, 2017
Promise of SGLT2 Inhibitors in Heart Failure: Diabetes and BeyondPieter Martens, Chantal Mathieu, Frederik H Verbrugge
Pageof 63

Showing results (41-50 of 625) with videos related to

Sort By:
Pageof 63
Expert Review of Proteomics|April 13, 2006
Type 1 diabetes: entering the proteomic eraWannes D'Hertog, Chantal Mathieu, Lut Overbergh
Current Opinion in Endocrinology, Diabetes, and Obesity|December 14, 2020
Advances in newer basal and bolus insulins: impact on type 1 diabetesJoke Vliebergh, Eveline Lefever, Chantal Mathieu
Therapeutic Advances in Endocrinology and Metabolism|August 13, 2020
SGLT inhibitors in type 1 diabetes: weighing efficacy and side effectsBirgit Janssens, Simon Caerels, Chantal Mathieu
Expert Review of Molecular Diagnostics|December 20, 2005
Quantification of chemokines by real-time reverse transcriptase PCR: applications in type 1 diabetesLut Overbergh, Conny Gysemans, Chantal Mathieu
The Journal of Endocrinology|March 17, 2021
100 YEARS OF INSULIN: Arresting or curing type 1 diabetes: an elusive goal, but closing the gapPieter-Jan Martens, Conny Gysemans, Chantal Mathieu
Molecular and Cellular Endocrinology|May 3, 2017
Vitamin D endocrinology on the cross-road between immunity and metabolismAn-Sofie Vanherwegen, Conny Gysemans, Chantal Mathieu
Endocrinology and Metabolism Clinics of North America|October 30, 2017
Regulation of Immune Function by Vitamin D and Its Use in Diseases of ImmunityAn-Sofie Vanherwegen, Conny Gysemans, Chantal Mathieu
Diabetes Care|April 29, 2011
Vitamin D deficiency is not good for youChantal Mathieu, Bart J Van der Schueren
The Proceedings of the Nutrition Society|September 17, 2002
1,25-dihydroxycholecalciferol: endocrinology meets the immune systemEvelyne van Etten, Brigitte Decallonne, Chantal Mathieu
Current Treatment Options in Cardiovascular Medicine|March 17, 2017
Promise of SGLT2 Inhibitors in Heart Failure: Diabetes and BeyondPieter Martens, Chantal Mathieu, Frederik H Verbrugge
Pageof 63